Previous Article | Next Article 
Journal of Virology, September 1998, p. 7648-7652, Vol. 72, No. 9
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Characterization of Proteolytic
Processing of the Pol Proteins of Human Foamy Virus Reveals
Novel Features of the Viral Protease
Klaus-Ingmar
Pfrepper,1
Hans-Richard
Rackwitz,2
Martina
Schnölzer,3
Hans
Heid,2
Martin
Löchelt,1 and
Rolf M.
Flügel1,*
Abteilungen Retroviral Gene Expression,
Research Program Applied Tumorvirology,1
Cell Biology, Research Program Cell Differentiation and
Carcinogenesis,2 and
Central Protein
Analysis Group,3 German Cancer Research
Center, 69009 Heidelberg, Federal Republic of Germany
Received 6 February 1998/Accepted 5 May 1998
 |
ABSTRACT |
Spumaviruses, or foamy viruses, express a pol-specific
transcript that codes for a Pol polyprotein that consists of
the protease, reverse transcriptase, ribonuclease H, and the integrase
domains. To delineate the proteolytic cleavage sites between
the Pol subdomains, recombinant human foamy virus (HFV) Pol proteins
were expressed, purified by affinity chromatography, and subjected to
either HFV protease assays or autocatalytic processing. In control
experiments, HFV protease-deficient mutant proteins in which the active
site Asp was replaced by an Ala residue were used to rule out
unspecific processing by nonviral proteases. Specific
proteolytic cleavage products were isolated, and the cleavage sites
were analyzed by amino acid sequencing. Peptides spanning the resulting
cleavage sites were chemically synthesized and assayed with HFV
protease, and the cleaved peptides were subjected to mass spectrometry. The cleavage site sequences obtained were in complete agreement with
the amino-terminal sequences from amino acid sequencing of authentic
cleavage products of the HFV Pol proteins. Analysis by fast-protein
liquid chromatography of a short version of the active HFV protease
revealed that the enzyme predominantly formed dimeric molecules.
 |
TEXT |
Human foamy virus (HFV) is the
prototypic spumavirus that has distinct features of gene expression
different from those of other known retroviruses. Foamy viruses (FVs)
as complex retroviruses express genes from two different promoters
(3, 13, 15), and unlike other retroviruses, HFV and feline
FV (FeFV) express subgenomic pol-specific transcripts
(1, 4, 16, 27). Although recombinant forms of the HFV Pol
proteins have been shown previously to express active HFV reverse
transcriptase (RT), RNase H (RH), and integrase (IN), to date,
proteolytic processing of HFV Pol proteins has not been analyzed, and
the precise interdomain cleavage sites of HFV Pol are unknown (2,
8, 14, 19, 21). Genetic analysis has shown that the HFV protease
(PR) is absolutely required for infectivity and processing, since the PR(D/A) mutant, in which the Asp residue was replaced by Ala, resulted
in a noninfectious HFV provirus (9). In HFV-infected cells,
the integrase has been shown to exist as a protein with a size of about
40 kDa, whereas the RT protein migrates as an 85-kDa protein (p85)
under denaturing conditions (16, 19). Both proteins were
shown to be derived from the pre127Pro-Pol polyprotein
(16).
To map the precise residues that flank a given cleavage site, the
following approaches were employed: (i) autocatalytic processing of
His-tagged HFV Pol proteins shortened at various defined positions, (ii) in vitro PR assays with incubation of an appropriate HFV Pro-Pol
protein that contained a suspected virus-specific cleavage site and
subsequent isolation of sufficient amounts of the resulting cleavage
products for amino acid microsequencing, and (iii) in vitro PR assays
with synthetic peptides that were chosen from the regions flanking the
putative HFV-specific cleavage sites. To rule out any unspecific
proteolytic cleavages, PR-deficient mutant proteins in which the Asp of
the active center of the viral PR was replaced by an Ala residue were
generated. In these control experiments, the PR(D/A) mutant proteins
were expressed in parallel, and the cleavage pattern was directly
compared to that of the authentic HFV Pol proteins. Three His-tagged
Pol polyproteins differing only in the COOH-terminal regions, namely
viral inserts 2, 3, and 6 (Fig. 1), were
cloned into the pET22b plasmid vector by PCR, expressed in
Escherichia coli BL21(DE3) cells, purified by affinity
chromatography on Ni2+-chelate columns, and reacted with a
polyclonal antiserum directed against HFV PR (20). The
immunoblot showed that the full-length proteins were expressed and
affinity purified, and the NH2-terminal PR domain reacted
with the PR antiserum (not shown). The apparent molecular masses of the
PR-RT-RH-
IN and PR-
RT Pol proteins were in close agreement with
the calculated values. As expected, the PR-RT-
RH protein migrated
slightly faster, consistent with previous reports (8).
Remarkably, the PR subdomain was retained in the three Pol proteins, as
shown by the positive immunoreaction with a polyclonal antiserum
directed against PR.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic diagram of the different forms of viral and
recombinant HFV Pol polyproteins. The top line represents the structure
of the HFV pre127Pro-Pol protein. Structures of viral
inserts cloned into pET22b vector plasmids are schematically shown in
lines 2, 3, and 6. Inserts 4 and 5 contain longer carboxy-terminal
extensions [TH(His)6-PRO(D/A)] of about 25 kDa to
facilitate solubility, immunodetection, and amino acid sequencing. M,
all inserts start with the authentic Met; TH, His-tagged thioredoxin
(20).
|
|
Upon close inspection, however, it was observed that in total bacterial
lysates, various expressed HFV Pol proteins were invariably accompanied
by autocatalytic processing (Fig. 2). To
show autocatalytically proteolytic processing, the pET22b plasmids
containing the HFV pol inserts were expressed in E. coli BL21(DE3) cells, and whole bacterial lysates analyzed by
immunoblotting. The 72-kDa HFV PR-RT-
RH protein was partially cut to
a smaller Pol protein of about 67 kDa (Fig. 2A, lane 1), which was a
specific cleavage product, since it was not detected in the control
reaction with the PR-inactive D/A mutant protein (lane 2). The same
specific cleavage product as that in lane 1 was identified upon
autocatalytic processing of PR-RT-RH-
IN (arrowhead 1+3 in Fig. 2A,
lane 3). During expression of the HFV PR-RT-RH-
IN protein, another
cleavage event must have occurred, since a novel band with a size of
about 85 kDa was observed in lane 3 (arrow 3). The additional cleavage
products were not observed because of their small molecular sizes of
about 3 to 4 kDa. Again, the cleavage products were not detectable in
the PR(D/A) mutant protein (lane 4). In order to obtain protein bands suitable for amino acid sequencing, Pol proteins were expressed with longer COOH-terminal extensions that contain another PR(D/A) sequence (Fig. 1) reactive with antiserum against HFV PR
(20). The viral inserts are schematically shown in Fig. 1 as
proteins 4 and 5. Bacterial expression and autocatalytic processing of the PR-RT-
RH-TH-PRO(D/A) and of
PR-RT-RH-
IN-TH-PRO(D/A) proteins is illustrated in Fig. 2B
in parallel with the double PR-deficient mutants. Both recombinant
proteins were autocatalytically processed to the cleavage product of
about 67 kDa observed previously (arrowhead 1+3) that corresponds to
the PR-RT domains shared by both proteins (lanes 1 and 3). In addition,
a relative large protein with a size of about 85 kDa was detectable in
lane 3 (labeled with arrow 3), as expected for a cleavage between the
RH and the IN domains of PR-RT-RH-
IN-TH-PRO(D/A) with one of the PR
domains active.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 2.
Bacterial expression and concomitant autocatalytic
processing of authentic and PR-deficient mutant Pol polyproteins. (A)
Immunoblots of the PR-RT- RH (lane 1) and the corresponding
PR-deficient D/A mutant proteins (lane 2); PR-RT-RH- IN and the
corresponding PR(D/A) mutant proteins (lanes 3 and 4) reacted with
antiserum against HFV PR. Arrowhead 1+3 marks the proteolytic cleavage
products with sizes of about 67 kDa in lanes 1 and 3; arrow 3 indicates
the reaction product with a size of 85 kDa in lane 3; M, marker
proteins with apparent molecular masses shown to the left. For the
structures of the HFV inserts, see Fig. 1. (B) Immunoblot of
PR-RT- RH-TH-PRO(D/A) (lane 1) and the corresponding PR-deficient
double D/A mutant proteins (lane 2) reacted with antibody against HFV
PR. Arrowhead 1+3 marks the PR-RT cleavage product p67, and arrowhead 1 marks a product with a size of about 27 kDa derived from the
carboxy-terminal part of insert 4 (Fig. 1). Panel B also represents an
immunoblot of processed PR-RT-RH- IN-TH-PRO(D/A) and the
corresponding PR(D/A) double mutant proteins (lanes 3 and 4). Arrowhead
1+3 points to the p67 PR-RT cleavage product, arrow 3 points to the p85
reaction product, and arrowhead 3 marks a product with a size of about
27 kDa derived from the COOH-terminal regions of HFV insert 5. Double
PR(D/A) mutant proteins served as controls (lanes 2 and 4).
|
|
It is noteworthy that two protein bands with sizes of about 27 kDa were
additionally identified (double arrowheads 1 and 3). These sizes are
consistent with the calculated values for the COOH-terminal extensions
of inserts 4 and 5. Importantly, a cleavage product with a relatively
high intensity of about 27 kDa was observed after autoprocessing of
insert 5. The PR-inactive D/A mutant proteins showed unspecific bands
that did not comigrate with the actual cleavage products in lanes 1 and
3. To determine the cleavage sites, the reaction products of 27 kDa
were affinity purified and subjected to amino acid microsequencing
(data not shown). The results revealed that the site where the amino
terminus of the integrase was cleaved from the RH domain consisted of
the sequence (NH2)-CNTKKPNLDA. The amino-terminal part
of the RT-RH cleavage site obtained by amino acid sequence analysis was
(NH2)-YTDGSAIKS (data not shown). Both sequences are
unique and occur at the appropriate locations in the HFV Pol protein
sequence deduced from nucleotide sequencing of the infectious HFV DNA
(12).
To independently confirm and prove the authenticity of the cleavage
sites, peptides that span the processing site were synthesized and
assayed in vitro by either the HFV PR-
RT-His or TH-PRO in the
presence of EDTA (20). Synthetic peptides that correspond to
the RH-IN and the RT-RH sites were subjected to PR assays, and
the cleavage products were analyzed by matrix-assisted laser desorption
ionization (MALDI) mass spectrometry (20). This analysis revealed that proteolytic cleavage of the two peptides
occurred at the sites marked by the vertical arrows TQGSYVVN
CNTKK
and PEGVF
YTDGSR, respectively, in agreement with the
known HFV sequences. The resulting cleavage sites are compiled in
Table 1. In parallel, apparent reaction
products after incubation with HFV PR-deficient D/A mutant proteins
were also subjected to analysis by MALDI mass spectrometry; mass peaks
with sizes that corresponded to specific reaction products were not
found.
So far, two processing sites of the HFV Pol protein have been
identified, namely those between the RT and RH and the RH and IN
domains. To determine which of the different proteolytically active
forms of PR-Pol was the shortest version, a 179-amino-acid-long recombinant Pol protein, PR-
RT-His (protein 6 in Fig. 1) that starts
from the first Met residue of Pol and extends to residue 159, followed
by a 14-amino-acid-long stretch of a vector-derived peptide sequence
and a hexa-His tag was subjected to analysis. The PR-
RT-His protein
was bacterially expressed and purified in parallel with the
corresponding PR-deficient D/A mutant in order to rule out unspecific
proteolytic cleavages. Surprisingly, autocatalytic processing of the
purified PR-
RT-His (21 kDa) protein exhibited three additional bands
that were identified after sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (Fig. 3) and characterized. N-terminal amino acid sequencing of the fastest-moving protein band (marked by two arrowheads in Fig. 3) resulted in the
sequence (NH2)-QVGHRKIR and another protein described
below. This sequence is located at position 144 of HFV Pol. Thus, the cleavage between the PR and the RT domains occurred at HWEN
QVGH (Table 1). The band moving at about 17 kDa was characterized as 143-residue-long HFV PR that was proteolytically active,
since it cleaved the p3Gag from the
pre74Gag (reference 20 and data not
shown).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
Autocatalytic processing of PR- RT-His proteins (viral
insert 6). (A) Gel electrophoretic analysis and staining with Coomassie
blue of PR-deficient D/A mutant PR- RT-His. Lane 1, PR- RT-His
protein; lane 2, band of the PR- RT-His substrate with a size of
about 21 kDa (arrow) and HFV PR as cleavage product of 17 kDa
(arrowhead). The product cleaved at residue 166 (from within the vector
backbone protein sequence) with a size of 19.6 kDa is marked with an
open circle) (see panel B); the double arrowhead marks the two
comigrating faint cleavage products of low molecular mass used for
N-terminal sequencing. M, low-molecular-mass markers. (B) Schematic
drawing of the proteolytically processed PR- RT-His protein cleaved
at sites 143 and 166 resulting in four cleavage products; the two
smaller peptides comigrated under the conditions used. Both the 3.5- and 1.5-kDa bands were microsequenced. N- and C-terminal residues are
in the one-letter amino acid code.
|
|
An additional cleavage product derived from processing of the HFV
PR-
RT-His protein of 179 amino acids was observed. Figure 3B
schematically shows the processing patterns. The analysis revealed that
a cleavage occurred within the vector-derived part of the recombinant
PR-
RT-His protein. Microsequencing identified this site as
KLAAALE(H), which is actually contained within the flanking sequencing
of the hexa-His tag of pET22b as SSSVD
KLAAALE(H)6. MALDI
mass spectrometry of the cleaved HFV PR-
RT-His protein confirmed
this result independently.
To analyze the molecular structure of the enzymatically active HFV PR,
PR-
RT-His protein was purified by Ni2+-chelate
affinity chromatography and subsequently subjected to fast-protein liquid chromatography (FPLC) in PR reaction
buffer on a Superose 12 HR10/30 column (Pharmacia)
calibrated with molecular size markers as shown in Fig.
4. The resulting elution profile clearly
showed two peaks in a region, as expected. The first eluted at
approximately 43 kDa, consistent with the dimeric form of the HFV
PR-
RT-His protein (Fig. 4). The second peak was eluted at about 20 kDa, consistent with the molecular size of the monomeric HFV
PR-
RT-His protein. Subsequent analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of both protein peaks eluted showed that not only the monomeric but also the dimeric PR-
RT-His peak comigrated as a protein band of 21 kDa, as expected. This result is in agreement with the properties of other retroviral enzymes of the aspartic PR family that were unambiguously shown to
exist as active homodimers (23, 25, 26). We identified three
cleavage sites of the HFV Pol polyprotein by means of immunoblots with
HFV PR-specific antisera, isolation of defined cleavage products from
soluble, affinity-purified recombinant proteins that contained authentic HFV Pol sequences, and subsequent amino acid sequencing. Residues spanning the cleavage sites were chemically synthesized; the
resulting peptides were subjected to proteolysis by the HFV PR
(10) and analyzed by MALDI mass spectrometry. The
PR-deficient D/A mutant proteins were consistently employed to control
the specificity of the proteolytic cleavages observed. Our data are consistent with the molecular sizes of virtually all HFV Pol proteins reported to occur in HFV-infected cells (5, 8, 16, 18). The
mature HFV Pol proteins encompass the integrase, the p85RT
that also contains the RH domain, and the p67RT. Since an
RH with the calculated value of 17 kDa was not detectable in
HFV-infected cells, it is likely that the active HFV RT consists of a
heterodimer of p85/p67 comparable to those of other retroviruses (7). Our results open the way to prove this hypothesis.
Since only N-terminal and no C-terminal sequencing was carried out, we
cannot rule out whether additional spacer peptides exist.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Identification of purified HFV PR- RT-His dimers by
FPLC separation. A Superose 12 HR10/30 column was calibrated with the
marker proteins as indicated at the top. HFV PR reaction buffer was
used to load and elute the affinity-purified HFV PR- RT-His protein
monomer and dimer.
|
|
As to the HFV PR, our data show that distinct forms of
PR were proteolytically active. One short form of HFV PR,
PR143, was capable of cleaving the HFV Gag precursor into p70 and p3
and the two peptides that link the RT-RH and the RH-IN domains (data not shown). One of the open questions is which form of the
proteolytically active HFV PR is responsible for the individual steps
of Pol processing in vivo.
It is noteworthy that forms of the HFV Pol proteins in which the PR
domain was removed were not consistently observed in infected cells.
The cleavage between the RH domain and the IN domain was faster and
more efficient than those of the two other sites that were cleaved with
suboptimal efficiency. This was also observed during proteolysis of the
corresponding junction peptides. It is worth mentioning that processing
of the site spanning the PR and RT was even less efficient. The poor
cleavage efficiency of this site might be one reason that only minute
amounts of PR143 are available for processing of FV Gag proteins that
in virus-infected cells has been reported to be invariantly incomplete
(14, 27). It seems possible that the PR-RT cleavage might
not be required for virus infectivity. The inefficient cleavage between
residues 143 and 144 may also be reflected by the fact that the PR143
did not cleave the corresponding peptides of various lengths that span
this site (data not shown). Close examination of the predicted secondary structures of HFV PR by the EMBL phd program (22) showed that FV PR-specific residues from 121 through 144 form a stable
alpha helix. A search program in the data banks revealed that
part of this HFV PR sequence from residues 128 to 139, KTLFVKYDNLWQ, was highly homologous
to an alpha-helical sequence,
KKLLTKYDNLFE (identical residues
are underlined), of the galactose-1-phosphate-uridyltransferase as
determined by X-ray crystallography (11, 24). The
three-dimensional structure of an FV PR will be required to solve this
question and related issues. Table 1 shows that FV PRs seem to prefer Val at the P2 or P2' position, the scissile bond being P1 and P1'
(23, 26). A comparison of the flap regions of well-studied retroviral PRs with those of the HFV PR illustrates large differences and relatively few common features (6, 17, 23, 26).
 |
ACKNOWLEDGMENTS |
We thank Helmut Bannert for excellent technical assistance,
Jennifer Reed for critically reading the manuscript, and Harald zur
Hausen for support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Abteilung
Retroviral Gene Expression, Applied Tumorvirology, DKFZ, INF 242, 69009 Heidelberg, Germany. Phone: 49-6221-424611. Fax: 49-6221-424865. E-mail: r.m.fluegel{at}dkfz-heidelberg.de.
 |
REFERENCES |
| 1.
|
Bodem, J.,
M. Löchelt,
I. Winkler,
R. P. Flower,
H. Delius, and R. M. Flügel.
1996.
Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses.
J. Virol.
70:9024-9027[Abstract].
|
| 2.
|
Coffin, J. M.
1996.
Retroviridae: the viruses and their replication, p. 1767-1847.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields' virology. Raven Press, New York, N.Y.
|
| 3.
|
Cullen, B. R.
1991.
Human immunodeficiency virus as a prototypic complex retrovirus.
J. Virol.
65:1053-1056[Free Full Text].
|
| 4.
|
Enssle, J.,
I. Jordan,
B. Mauer, and A. Rethwilm.
1996.
Foamy virus reverse transcriptase is expressed independently from the Gag protein.
Proc. Natl. Acad. Sci. USA
93:4137-4141[Abstract/Free Full Text].
|
| 5.
|
Giron, M.-L.,
F. Rozain,
M. C. Debons-Guillemin,
M. Canivet,
J. Peries, and R. Emanoil-Ravier.
1993.
Human foamy virus polypeptides: identification of env and bel gene products.
J. Virol.
67:3596-3600[Abstract/Free Full Text].
|
| 6.
|
Hayakawa, T.,
Y. Misumi,
M. Kobayashi,
Y. Yamamoto, and Y. Fujisawa.
1992.
Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease.
Eur. J. Biochem.
206:919-925[Medline].
|
| 7.
|
Katz, R. A., and A. M. Skalka.
1994.
The retroviral enzymes.
Annu. Rev. Biochem.
63:133-173[Medline].
|
| 8.
|
Kögel, D.,
M. Aboud, and R. M. Flügel.
1995.
Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains.
Virology
213:97-108[Medline].
|
| 9.
|
Konvalinka, J.,
M. Löchelt,
H. Zentgraf,
R. M. Flügel, and H.-G. Kräusslich.
1995.
Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein.
J. Virol.
69:7264-7268[Abstract].
|
| 10.
|
Kotler, M.,
R. A. Katz,
W. Danho,
J. Leis, and A. M. Skalka.
1988.
Synthetic peptides as substrates and inhibitors of a retroviral protease.
Proc. Natl. Acad. Sci. USA
85:4185-4189[Abstract/Free Full Text].
|
| 11.
|
Leslie, N. D.,
E. B. Immerman,
J. E. Flach,
M. Florez,
J. L. Fridovich-Keil, and L. J. Elsas.
1992.
The human galactose1-phosphate uridyltransferase gene.
Genomics
14:474-480[Medline].
|
| 12.
|
Löchelt, M.,
H. Zentgraf, and R. M. Flügel.
1991.
Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.
Virology
184:43-54[Medline].
|
| 13.
|
Löchelt, M.,
W. Muranyi, and R. M. Flügel.
1993.
Human foamy virus genome possesses an internal, Bel 1-dependent and functional promoter.
Proc. Natl. Acad. Sci. USA
90:7317-7321[Abstract/Free Full Text].
|
| 14.
|
Löchelt, M., and R. M. Flügel.
1995.
The molecular biology of primate spumaviruses, p. 239-292.
In
J. A. Levy (ed.), The Retroviridae, vol. 4. Plenum Press, New York, N.Y.
|
| 15.
|
Löchelt, M.,
S. F. Yu,
M. L. Linial, and R. M. Flügel.
1995.
The human foamy virus internal promoter is required for efficient gene expression and infectivity.
Virology
206:601-610[Medline].
|
| 16.
|
Löchelt, M., and R. M. Flügel.
1996.
The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein.
J. Virol.
70:1033-1040[Abstract].
|
| 17.
|
Miller, M.,
M. Jaskolski,
J. K. M. Rao,
J. Leis, and A. Wlodawer.
1989.
Crystal structure of a retroviral protease proves relationship to aspartic protease family.
Nature
337:576-579[Medline].
|
| 18.
|
Netzer, K.-O.,
A. Schliephake,
B. Maurer,
R. Watanabe,
A. Aguzzi, and A. Rethwilm.
1993.
Identification of pol-related gene products of human foamy virus.
Virology
192:336-338[Medline].
|
| 19.
|
Pahl, A., and R. M. Flügel.
1993.
Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus.
J. Virol.
67:5426-5434[Abstract/Free Full Text].
|
| 20.
|
Pfrepper, K.-I.,
M. Löchelt,
M. Schnölzer, and R. M. Flügel.
1997.
Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease.
Biochem. Biophys. Res. Commun.
237:548-553[Medline].
|
| 21.
|
Rethwilm, A.
1995.
Regulation of foamy virus gene expression.
Curr. Top. Microbiol. Immunol.
193:1-24[Medline].
|
| 22.
|
Rost, B., and C. Sander.
1994.
Combining evolutionary information and neural networks to predict protein secondary structure.
Proteins
9:55-72.
|
| 23.
|
Skalka, A. M.
1989.
Retroviral proteases: first glimpses at the anatomy of a processing machine.
Cell
56:911-913[Medline].
|
| 24.
|
Wedekind, J. E.,
P. A. Frey, and I. Rayment.
1995.
Three-dimensional structure of galactose-1-phosphate uridyltransferase from E. coli at 1.8 A resolution.
Biochemistry
34:11049-11061[Medline].
|
| 25.
|
Wlodawer, A.,
M. Miller,
M. Jaskolski,
B. K. Sathyanarayana,
E. Baldwin,
I. T. Weber,
L. M. Selk,
L. Clawson,
J. Schneider, and S. B. H. Kent.
1989.
Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.
Science
245:616-621[Abstract/Free Full Text].
|
| 26.
|
Wlodawer, A., and J. Erickson.
1993.
Structure-based inhibitors of HIV-1.
Annu. Rev. Biochem.
62:543-585[Medline].
|
| 27.
|
Yu, S. F.,
D. N. Baldwin,
S. R. Gwynn,
S. Yendapalli, and M. L. Linial.
1996.
Human foamy virus replication a pathway distinct from that of retroviruses and hepadnaviruses.
Science
271:1579-1582[Abstract].
|
Journal of Virology, September 1998, p. 7648-7652, Vol. 72, No. 9
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., Cherepanov, P.
(2009). Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res
37: 243-255
[Abstract]
[Full Text]
-
Hartl, M. J., Kretzschmar, B., Frohn, A., Nowrouzi, A., Rethwilm, A., Wohrl, B. M.
(2008). AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP. Nucleic Acids Res
36: 1009-1016
[Abstract]
[Full Text]
-
Roy, J., Linial, M. L.
(2007). Role of the Foamy Virus Pol Cleavage Site in Viral Replication. J. Virol.
81: 4956-4962
[Abstract]
[Full Text]
-
Sperka, T., Boross, P., Eizert, H., Tozser, J., Bagossi, P.
(2006). Effect of mutations on the dimer stability and the pH optimum of the human foamy virus protease. Protein Eng Des Sel
19: 369-375
[Abstract]
[Full Text]
-
Abram, M. E., Parniak, M. A.
(2005). Virion Instability of Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) Mutated in the Protease Cleavage Site between RT p51 and the RT RNase H Domain. J. Virol.
79: 11952-11961
[Abstract]
[Full Text]
-
Boyer, P. L., Stenbak, C. R., Clark, P. K., Linial, M. L., Hughes, S. H.
(2004). Characterization of the Polymerase and RNase H Activities of Human Foamy Virus Reverse Transcriptase. J. Virol.
78: 6112-6121
[Abstract]
[Full Text]
-
Verschoor, E. J., Langenhuijzen, S., van den Engel, S., Niphuis, H., Warren, K. S., Heeney, J. L.
(2003). Structural and Evolutionary Analysis of an Orangutan Foamy Virus. J. Virol.
77: 8584-8587
[Abstract]
[Full Text]
-
Rinke, C. S., Boyer, P. L., Sullivan, M. D., Hughes, S. H., Linial, M. L.
(2002). Mutation of the Catalytic Domain of the Foamy Virus Reverse Transcriptase Leads to Loss of Processivity and Infectivity. J. Virol.
76: 7560-7570
[Abstract]
[Full Text]
-
Yvon-Groussin, A., Mugnier, P., Bertin, P., Grandadam, M., Agut, H., Huraux, J. M., Calvez, V.
(2001). Efficacy of Dideoxynucleosides against Human Foamy Virus and Relationship to Its Reverse Transcriptase Amino Acid Sequence and Structure. J. Virol.
75: 7184-7187
[Abstract]
[Full Text]
-
Imrich, H., Heinkelein, M., Herchenröder, O., Rethwilm, A.
(2000). Primate foamy virus Pol proteins are imported into the nucleus. J. Gen. Virol.
81: 2941-2947
[Abstract]
[Full Text]
-
Tobaly-Tapiero, J., Bittoun, P., Neves, M., Guillemin, M.-C., Lecellier, C.-H., Puvion-Dutilleul, F., Gicquel, B., Zientara, S., Giron, M.-L., de Thé, H., Saïb, A.
(2000). Isolation and Characterization of an Equine Foamy Virus. J. Virol.
74: 4064-4073
[Abstract]
[Full Text]
-
Pfrepper, K.-I., Löchelt, M., Rackwitz, H.-R., Schnölzer, M., Heid, H., Flügel, R. M.
(1999). Molecular Characterization of Proteolytic Processing of the Gag Proteins of Human Spumavirus. J. Virol.
73: 7907-7911
[Abstract]
[Full Text]
-
Baldwin, D. N., Linial, M. L.
(1999). Proteolytic Activity, the Carboxy Terminus of Gag, and the Primer Binding Site Are Not Required for Pol Incorporation into Foamy Virus Particles. J. Virol.
73: 6387-6393
[Abstract]
[Full Text]
-
Linial, M. L.
(1999). Foamy Viruses Are Unconventional Retroviruses. J. Virol.
73: 1747-1755
[Full Text]
-
Mulder, L. C. F., Muesing, M. A.
(2000). Degradation of HIV-1 Integrase by the N-end Rule Pathway. J. Biol. Chem.
275: 29749-29753
[Abstract]
[Full Text]